PathoQuest, a life sciences spin-out of the Pasteur Institute and the Ecole Nationale Vétérinaire d’Alfort (ENVA), has raised €3.8m ($5m) in series B private equity (PE) funding.

Participants in the round were PE firms IDInvest Partners, Kurma Life Science Partners, and Aurinvest.

The funding will be used to fuel Paris-based PathoQuest’s trials and technology development. The firm is working on next-generation infectious disease diagnostic arrays, which it plans to launch in 2015.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?